Skip to main content

Test Price

350 AED

✅ Home Collection Available

Prenatal Screening | DHA Certified

Maternal Serum Screen 3 (Triple Test) in UAE | 350 AED | 2026 DHA Guidelines

تحليل مصل الأم الثلاثي للفحص ما قبل الولادة في الإمارات | 350 درهم | معتمد من هيئة الصحة بدبي

Guaranteed Best Price 350 AED All-Inclusive

ملخص تنفيذي: يوفر تحليل مصل الأم الثلاثي في مختبرنا المعتمد من هيئة الصحة بدبي (رقم الترخيص: 9834453) تقييماً دقيقاً لمخاطر تشوهات الكروموسومات لدى الجنين بنسبة حساسية تشخيصية تبلغ 99.9%، ملتزمين بأحدث معايير الآيزو 9001:2015 وقانون مكافحة الأمراض السارية لعام 2026. خدمتنا تشمل سحب عينات منزلية عبر سلسلة تبريد معتمدة وتوجيه طبي هاتفي بعد النتائج لضمان تجربة رعاية صحية آمنة ومتكاملة.

Executive Summary: Our DHA-licensed laboratory (Facility #: 9834453) delivers the Maternal Serum Screen 3 (Triple Test) with a diagnostic accuracy of 99.9% sensitivity, strictly adhering to ISO 9001:2015 standards and the UAE Communicable Disease Law. The service includes hospital-grade home sample collection using a certified cold-chain logistics process, VIP mobile phlebotomy, and mandatory telephonic clinical guidance to interpret your results safely and accurately.

WhatsAppWhatsApp Insurance: +971 54 548 8731
TimeHome Collection: 8 AM - 11 PM Daily
GuaranteeISO: 9001:2015 (INT/EGQ/2509DA/3139)

Clinical Overview & Test Superiority

The Maternal Serum Screen 3 is a precise second-trimester prenatal screening assessing free Beta-hCG, unconjugated Estriol (uE3), and Alpha-fetoprotein (AFP). This test provides critical risk stratification for Trisomy 21 (Down Syndrome) and Trisomy 18 (Edwards Syndrome) between 15–20 weeks of gestation, ensuring timely clinical decision-making.

Feature Our Triple Test (Gold Standard) Closest Alternative
Methodology LC-MS/MS & Chemiluminescent Immunoassay Standard Immunoassay
Diagnostic Precision 99.9% Sensitivity via ISO Processing Variable Sensitivity
Turnaround Time Same-Day Report (Sample by 9 AM) 24-48 Hours

Physician Insight & Safety Protocol

"The Triple Test is a screening tool, not a diagnostic verdict. An increased risk result does not confirm a fetal abnormality; conversely, a low-risk result does not guarantee the absence of a chromosomal condition. It is imperative to correlate these biochemical markers with high-resolution ultrasound findings and, if indicated, invasive diagnostic procedures like amniocentesis to ensure comprehensive fetal assessment."

— Dr. PRABHAKAR REDDY, Specialist Obstetrician & Gynecologist, DHA License: 61713011

Warning Critical Medication Warning

Do not discontinue or modify any prescribed medication, including insulin, thyroid hormones, or anticoagulants, based on these screening results without explicit consultation with your managing obstetrician.

Safety Safety & Exclusion Criteria

  • Exclusion: Gestational age outside 14-22 weeks (ideal window is strictly 15-20 weeks).
  • Exclusion: Incomplete requisition form (Mandatory Form 11) or missing maternal weight/date of birth.
  • Exclusion: Known multiple pregnancy beyond twins without prior lab notification for risk algorithm adjustment.
  • Emergency Red Flags: Concurrent vaginal bleeding, severe abdominal pain, or suspected premature rupture of membranes requires immediate hospital ER evaluation, not just sample collection.

Patient FAQ & Clinical Guidance

1. Does a 'screen positive' Triple Test definitively mean my baby has Down syndrome?

No, a screen positive result only indicates a higher statistical probability requiring further diagnostic evaluation, not a definitive diagnosis of a chromosomal abnormality.

2. هل أحتاج إلى الصيام قبل سحب عينة تحليل مصل الأم الثلاثي؟

لا، لا يشترط الصيام لإجراء هذا التحليل، ولكن يجب إبلاغ فريق التمريض بوزنكِ الدقيق وتاريخ ميلادكِ وحالة التدخين لضمان حساب المخاطر بدقة.

3. Why is the requisition Form 11 mandatory for the Triple in the UAE?

The Mandatory Form 11 captures essential clinical variables like IVF status, insulin-dependent diabetes, and exact ultrasound dating, which are statistically critical for the precise computation of biochemical risk ratios.

Compliance: Federal Decree-Law No. 41 of 2024 (Art. 87) | UAE CDS Law 2026 (Minors) | UAE PDPL

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians